Massimo Squatrito (@GlioVis) profile picture
Joined October 2015
Photo by Massimo Squatrito (@GlioVis)Photo by Massimo Squatrito (@GlioVis)Photo by Massimo Squatrito (@GlioVis)Photo by Massimo Squatrito (@GlioVis)Photo by Massimo Squatrito (@GlioVis)
This is really exciting! I'm glad that we have contributed to it. @bowman_rl @roelverhaak #neuro-oncology
14
Congratulations Veronica for the stellar presentation! Special thanks to all the members of the tribunal: Paola Bovolenta, Paco Real, Marta Alonso, @gliomalab, @ggargiul_2020
🎓 Congratutations Verónica Matía on becoming a #PhD holder today #CNIOStopCancer "Unraveling Novel Transcriptional Networks Regulating Diffuse Midline Glioma Development" 🎉🎉 🙌 Wishing you the best in your career ahead, Verónica
11
Massimo Squatrito retweeted
🎓 Congratutations Verónica Matía on becoming a #PhD holder today #CNIOStopCancer "Unraveling Novel Transcriptional Networks Regulating Diffuse Midline Glioma Development" 🎉🎉 🙌 Wishing you the best in your career ahead, Verónica
2
1
13
Massimo Squatrito retweeted
#NoticiasCNIO | El equipo de Massimo Squatrito @GlioVis descubre junto a investigadores de @SciMed_unifr el gen master regulator del subtipo de cáncer cerebral con peor pronóstico, el glioblastoma mesenquimal ▶️cnio.es/noticias/descubren-e…
1
13
2
31
Massimo Squatrito retweeted
#CNIOnews | Massimo Squatrito’s lab @GlioVis and scientists from @SciMed_unifr find the master regulator gene for the mesenchymal subtype of glioblastoma, the brain cancer with the poorest prognosis @eLife cnio.es/en/news/a-master-reg…
1
2
9
NF1 had been previously shown to be frequently inactivated in mesenchymal GBM. Here we describe that NF1 loss through the activation of the RAS/MAPK signalling leads to the upregulation of the AP1 transcription factor FOSL1 that in turn regulates the mesenchymal gene program
1
5
Last, but not least, thanks to the @SaludISCIII and @SeveBallesteros Foundation for their support!!
3
May is Brain Tumor Awareness Month and today is the 10th anniversary of #Seve Ballesteros' passing. We HAVE TO do more for GBM patients! At the @SeveBallesteros Foundation lab at @CNIOStopCancer we work to identify novel treatments for this devastating disease. #GoGrayinMay
8
Very excited to share our latest work @MCT_AACR from the @SeveBallesteros Brain Tumor Group @CNIOStopCancer on overcoming multiple temozolomide resistance mechanisms in glioblastoma 1/n mct.aacrjournals.org/content…
3
3
20
Congratulations to all the authors and thanks to the @SeveBallesteros Foundation and the @aecc_es for their support!! 2/n
1
(1/7) How do #epithelial #cancer #cells regulate their plasticity? In our latest paper, we uncovered chromatin modulators whose loss affects epithelial-mesenchymal interconversion in opposite directions (advances.sciencemag.org/cont…).
8
25
3
104
Massimo Squatrito retweeted
Recently published #OnlineFirst: Phenotypic mapping of pathological crosstalk between #glioblastoma and innate immune cells by synthetic genetic tracing. @ggargiul_2020 @MDC_Berlin https://nitter.cf/t.co/Kgvu2YOkhk
1
7
16
I am very happy that I had the opportunity to give a small contribute to this awesome work from the @ggargiul_2020 lab @MCD_Berlin!! Phenotypic mapping of pathological crosstalk between glioblastoma and innate immune cells by synthetic genetic tracing cancerdiscovery.aacrjournals…
1
6
3/ Among the different innate immune cell types, the microglia appear to divert glioblastoma cells to a proneural-to-mesenchymal transition which confers therapeutic resistance.
1
1
4/ Stay tuned for more exciting work from the @ggargiul_2020 using the synthetic genetic tracing methodology!!
1
Our paper is finally out! We established causal links between clinically relevant covariates and the most aggressive brain tumor state, the mesenchymal glioblastoma. Our technology is generally applicable to complex phenotypes! Thanks to the team/funders! cancerdiscovery.aacrjournals…
8
24
4
94